UNSPSC 51182037: Norclostebol

This classification denotes an anabolic steroid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VI1001O2DI. European Medicines Agency schedules Norclostebol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09356MIG. Norclostebol generally arises in the molecular formula C18H25CLO2. The term NORCLOSTEBOL is an International Non-Proprietary Name or INN. NORCLOSTEBOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule norclostebol under HS 29372900 and SITC 54153. As of Q4 2014, NORCLOSTEBOL remains the US FDA Preferred Term for this commodity. Norclostebol bears US NLM identifiers UMLS ID C2698495 and NCI Concept Code C77307. SMILES: CLC1=C2C(C3C(C4C(CC3)(C(O)CC4)C)CC2)CCC1=O.

UNSPSC 51182037 Norclostebol is a Commodity code that covers anabolic steroid pharmaceuticals and related controlled substances. State and local government procurement under this code appears limited to inclusion within broader pharmaceutical supply agreements rather than standalone purchases of norclostebol itself. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products, issued in January 2026, represents the primary recent solicitation activity. MMCAP administers cooperative purchasing agreements on behalf of participating state and local government facilities across multiple states, including Oregon and Minnesota, consolidating procurement across dozens of state agencies, counties, cities, and other public entities. The focus is on establishing pharmaceutical supply relationships through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) with vendors offering comprehensive product catalogs, competitive pricing, and compliance with Good Manufacturing Practices and Drug Supply Chain Security Act requirements.

MMCAP's cooperative purchasing vehicle dominates recent activity in this commodity code tier, with the January 2026 RFP representing the most substantial solicitation. The RFP closed to questions on February 18, 2026, with proposals due March 26, 2026, and awarded vendors to be listed by May 15, 2026 for July 1, 2026 contract effectiveness. Evaluation weighted price competitiveness most heavily (75 percent), followed by fixed pricing (10 percent), with smaller weights on administrative compliance (5 percent), EDI capability (5 percent), and fee agreement (5 percent). Vendors must maintain $5 million commercial general liability insurance, $2 million network security and privacy liability, and $2 million professional liability. Contract terms run two years for new vendors with optional extensions, while incumbent amendments extend through June 30, 2028. No set-aside designations or restricted competition categories are disclosed in the available documentation.